Table 3.
Multivariate Logistic Regression Analyses
| Established Care | Met Retention Criterion in All Outpatient Years | No Loss to Follow-up > 12 months | Met all Three Criteria | |
|---|---|---|---|---|
| Gender | ||||
| Female | ---- | ---- | ---- | ---- |
| Male | 0.81 (0.71, 0.93)** | 0.90 (0.80, 1.01) | 0.87 (0.75 1.01) | 0.82 (0.72, 0.93)** |
| Race/Ethnicity | ||||
| White | ---- | ---- | ---- | ---- |
| Black | 1.16 (1.08, 1.24)*** | 0.88 (0.82, 0.95)*** | 1.32 (1.12, 1.56)*** | 1.07 (0.98, 1.16) |
| Hispanic | 1.26 (1.05, 1.50)* | 1.03 (0.97, 1.09) | 1.37 (1.12, 1.68)** | 1.24 (1.07, 1.44)** |
| Other | 1.05 (0.81, 1.37) | 1.01 (0.82, 1.24) | 1.01 (0.77, 1.33) | 1.05 (0.90, 1.22) |
| Missing | 0.46 (0.37, 0.58)*** | 0.91 (0.64, 1.28) | 0.74 (0.44, 1.25) | 0.56 (0.37, 0.86)** |
| Risk Group | ||||
| MSM | ---- | ---- | ---- | ---- |
| HET | 0.87 (0.80, 0.94)** | 0.85 (0.76, 0.96)** | 1.04 (0.93, 1.16) | 0.83 (0.74, 0.94)** |
| IDU | 0.51 (0.44, 0.59)*** | 0.86 (0.70, 1.06) | 0.66 (0.57, 0.77)*** | 0.58 (0.49, 0.68)*** |
| HET+IDU | 0.96 (0.70, 1.32) | 0.86 (0.70, 1.04) | 0.89 (0.75, 1.07) | 0.79 (0.59, 1.06) |
| MSM+IDU | 1.07 (0.78, 1.46) | 0.91 (0.79, 1.05) | 0.93 (0.70, 1.22) | 0.85 (0.61, 1.17) |
| Missing | 0.27 (0.15, 0.48)*** | 1.14 (0.95, 1.38) | 0.47 (0.26, 0.88)* | 0.40 (0.21, 0.77)** |
| Age at Enrollment | ||||
| 18-29 | ---- | ---- | ---- | ---- |
| 30-39 | 1.04 (0.96, 1.12) | 1.14 (1.07, 1.20)*** | 1.08 (0.94, 1.24) | 1.16 (1.04, 1.28)*** |
| 40-49 | 1.19 (1.04, 1.37)** | 1.31 (1.22, 1.40)*** | 1.25 (1.11, 1.42)*** | 1.48 (1.34, 1.64)*** |
| 50+ | 1.36 (1.24, 1.49)*** | 1.54 (1.37, 1.72)*** | 1.57 (1.35, 1.84)*** | 1.92 (1.67, 2.21)*** |
| Initial Insurance | ||||
| Private | ---- | ---- | ---- | ---- |
| Medicaid | 0.85 (0.72, 1.01) | 1.03 (0.87, 1.23) | 0.94 (0.75, 1.17) | 0.93 (0.74, 1.18) |
| Medicare/Dual | 0.76 (0.61, 0.95)* | 1.30 (1.12, 1.51)** | 0.94 (0.72, 1.24) | 1.11 (0.89, 1.38) |
| None/Ryan White | 0.77 (0.57, 1.03) | 1.01 (0.91, 1.12) | 0.96 (0.83, 1.12) | 0.93 (0.78, 1.06) |
| Missing | 0.93 (0.79, 1.10) | 0.86 (0.64, 1.16) | 0.99 (0.80, 1.24) | 0.93 (0.69, 1.24) |
| Initial CD4 Cell Count | ||||
| <50 | ---- | ---- | ---- | ---- |
| 51-200 | 1.08 (0.91, 1.28) | 0.86 (0.81, 0.91)*** | 0.77 (0.67, 0.90)*** | 0.77 (0.70, 0.86)*** |
| 201-350 | 0.95 (0.78, 1.15) | 0.86 (0.76, 0.96)* | 0.74 (0.61, 0.90)** | 0.73 (0.62, 0.85)** |
| 351-500 | 0.97 (0.78, 1.19) | 0.79 (0.71, 0.88)*** | 0.71 (0.59, 0.86)*** | 0.69 (0.60, 0.79)*** |
| 501+ | 0.91 (0.76, 1.08) | 0.78 (0.70, 0.86)*** | 0.65 (0.53, 0.81)*** | 0.62 (0.57, 0.68)*** |
| Missing | 6.57 (4.15,10.40)*** | 0.47 (0.36, 0.61)*** | 0.71 (0.55, 0.93)** | 0.58 (0.40, 0.82)*** |
| Year of First Visit | ||||
| 2001 | ---- | ---- | ---- | ---- |
| 2002 | 1.44 (0.97, 2.13) | 1.10 (1.01, 1.21)* | 1.16 (0.99, 1.34) | 1.50 (1.08, 2.07)** |
| 2003 | 1.59 (0.96, 2.63) | 1.27 (1.06, 1.52)* | 1.27 (1.08, 1.49)*** | 1.83 (1.27, 2.63)*** |
| 2004 | 1.10 (0.77, 1.59) | 1.42 (1.22, 1.64)*** | 1.35 (1.12, 1.64)*** | 1.77 (1.24, 2.54)*** |
| 2005 | 0.97 (0.61, 1.55) | 1.48 (1.32, 1.67)*** | 1.74 (1.38, 2.20)*** | 2.17 (1.50, 3.16)*** |
| 2006 | 1.04 (0.69, 1.59) | 1.72 (1.43, 2.07)*** | 2.62 (2.09, 3.30)*** | 3.17 (2.36, 4.25)*** |
| 2007 | 0.98 (0.67, 1.43) | 1.99 (1.53, 2.58)*** | 4.45 (3.54, 5.61)*** | 3.88 (2.62, 5.72)*** |
| 2008 | 0.84 (0.60, 1.18) | 2.97 (2.45, 3.60)*** | 20.92 (16.34, 26.77)** | 6.89 (4.62, 10.02)*** |
| First HIV-1 RNA | ||||
| Not suppressed | ---- | ---- | ---- | ---- |
| Suppressed | 1.13 (0.98, 1.31) | 1.06 (1.01, 1.10)* | 1.04 (0.93, 1.16) | 1.11 (0.99, 1.24) |
| Missing | 0.92 (0.66, 1.30) | 0.91 (0.71, 1.16) | 1.08 (0.92, 1.26) | 0.91 (0.68, 1.21) |
Note: Entries are adjusted odds-ratios (95% CIs). MSM – Men who have sex with men; IDU – injection drug use; HET – heterosexual transmission. All models included indicators for treatment site.
*
p<0.05
**
p<0.01
***
p< 0.001